| Vinflunine studied in …STUDIED_INderived26 of 26show fewer |
|---|
| → studied in | NCT03390504Phase 3 · active not recruiting A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations · 26 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07419295Phase 3 · recruiting A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) · 26 trials list this drug (2 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04527991Phase 3 · completed Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread · 26 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03474107Phase 3 · completed A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) · 26 trials list this drug (2 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00545766Phase 2 · completed Vinflunine in Hormone Refractory Prostate Cancer (HRPC) · 26 trials list this drug (2 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02256436Phase 3 · completed A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045) · 26 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02057913Phase 2 · completed A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP) · 26 trials list this drug (2 active) | — | — | Penile Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02665039Phase 2 · completed A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function · 26 trials list this drug (2 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm,Malignant Ureter Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01091168Phase 3 · completed Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer · 26 trials list this drug (2 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02302807Phase 3 · completed A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] · 26 trials list this drug (2 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01953003Phase 3 · completed Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer · 26 trials list this drug (2 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01844947Phase 1 · completed Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract · 26 trials list this drug (2 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm,Malignant Ureter Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01529411Phase 2 · completed Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer · 26 trials list this drug (2 active) | — | — | Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02347332Phase 3 · completed Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer · 26 trials list this drug (2 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02845050Phase 1/Phase 2 · withdrawn Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO) · 26 trials list this drug (2 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00519831Phase 2 · terminated Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC · 26 trials list this drug (2 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450515Phase 2 · withdrawn Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer · 26 trials list this drug (2 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00389155Phase 2/Phase 3 · completed First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy · 26 trials list this drug (2 active) | — | — | Transitional Cell Carcinoma,Bladder Neoplasm,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00534807Phase 1 · withdrawn A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer · 26 trials list this drug (2 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01830231Phase 2/Phase 3 · unknown Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU) · 26 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00284180Phase 2 · completed Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer · 26 trials list this drug (2 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00284154Phase 2 · completed Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer · 26 trials list this drug (2 active) | — | — | Malignant Lung Neoplasm,Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00320073Phase 1 · completed Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors · 26 trials list this drug (2 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00251446Phase 2 · completed A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer · 26 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101608Phase 2 · completed Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium · 26 trials list this drug (2 active) | — | — | Transitional Cell Carcinoma,Bladder Neoplasm,Kidney Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00359476Phase 2/Phase 3 · terminated A Study of Vinflunine in Patients With Gastric Cancer · 26 trials list this drug (2 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |